The Use of Alloderm in Two-Stage, Tissue Expander/Implant Reconstruction: A Single-Blinded, Randomized, Controlled Trial
Interventional
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment
whether using Alloderm to create the inferior-medial portion of the expander pocket will decrease patient-reported pain in both the immediate, post-operative period and during the expansion phase.
conclusion of the study
No
Joseph Disa, MD
Principal Investigator
Memorial Sloan-Kettering Cancer Center
United States: Institutional Review Board
08-024
NCT00639106
March 2008
March 2013
Name | Location |
---|---|
Memorial Sloan Kettering Cancer Center | New York, New York 10021 |
University of Michigan Health System | Ann Arbor, Michigan |
University of North Carolina School of Medicine | Chapel Hill, North Carolina 27599 |